Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141987 |
| CAS No | NA |
| Mol.F. | C₁₅H₂₂N₂O₅ |
| Mol.Wt. | 310.35 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141988 |
| CAS No | 25413-64-3 |
| Mol.F. | C7H16N2O |
| Mol.Wt. | 144.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141989 |
| CAS No | NA |
| Mol.F. | C17H25N3O2 |
| Mol.Wt. | 303.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141990 |
| CAS No | 56420-30-5 |
| Mol.F. | C10H18N2O |
| Mol.Wt. | 182.26 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141991 |
| CAS No | NA |
| Mol.F. | C10H15N3O2 |
| Mol.Wt. | 209.24 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141992 |
| CAS No | 80508-23-2 |
| Mol.F. | C9H11N3O |
| Mol.Wt. | 177.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141993 |
| CAS No | NA |
| Mol.F. | C8H16N2O |
| Mol.Wt. | 156.23 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141994 |
| CAS No | NA |
| Mol.F. | C7H6N4O6 |
| Mol.Wt. | 242.1 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141995 |
| CAS No | NA |
| Mol.F. | C3H4N4O3 |
| Mol.Wt. | 144.09 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141996 |
| CAS No | 3053220-60-0 |
| Mol.F. | C6H10N2O |
| Mol.Wt. | 126.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141997 |
| CAS No | 86594-16-3 |
| Mol.F. | C4H6N2O3S |
| Mol.Wt. | 162.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141998 |
| CAS No | NA |
| Mol.F. | C8H15N3O |
| Mol.Wt. | 169.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141999 |
| CAS No | NA |
| Mol.F. | C8H18N6O2 |
| Mol.Wt. | 230.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142000 |
| CAS No | 73742-56-0 |
| Mol.F. | C6H11N3O2 |
| Mol.Wt. | 157.2g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142001 |
| CAS No | 10589-74-9 |
| Mol.F. | C6H13N3O2 |
| Mol.Wt. | 159.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142002 |
| CAS No | 2089333-06-0 |
| Mol.F. | C9H17N3O2 |
| Mol.Wt. | 199.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |